|
Time
tested remedies | Most affordable prices
|
 |
|
Neurofibromatosis Type 2 (NF-2)
| Treatment No. : |
RD0498 |
| Dosage & Instructions: |
15 drops in 15 ml of plain water twice a day,
mornings and evenings.
|
| Composition: |
Agraphis nutans D30+100C
Calc fluor D200+200C
Chenopodium D200+200C
Elaps D30+100C
Cherianthus cheiri D30+100C
China sulph D200+200C
Rosa damascus D30+100C
Verbascum D30+100C |
| Treatment Type: |
This remedy is a symptomatic treatment. A symptomatic treatment cannot eliminate the disease from its root but is able to considerably improve the patient's condition by easing
his or her symptoms.
|
| Contra-indications: |
None established |
| Special Instructions: |
Whereas this remedy can be safely used by teenagers, its use has not been evaluated in children under 12 years of age. Please do not administer to children under this age.
|
| Storage: |
Store in a cool and dry place |
| Precautions: |
Keep away from the reach of children |
| Standard Packaging : |
30 ml Drops |
|
Order Online:
|
One 30 ml bottle for $79.99
Two 30 ml bottles for $129.99
|
Condition Overview: Neurofibromatosis Type 2 (NF-2) is a rare genetic disorder that is primarily characterized by benign (noncancerous) tumors of the nerves that transmit sound impulses from the inner ears to the brain (bilateral acoustic neuromas vestibular schwannomas). Associated symptoms and findings may become evident during childhood, adolescence, or early adulthood. Depending on the exact location and size of the acoustic neuromas/vestibular schwannomas, such findings may include disturbances of balance and walking (gait); dizziness; headache; facial weakness, numbness, or pain; ringing in the ears (tinnitus); and/or progressive hearing loss.
In some individuals with NF-2, additional abnormalities may also be present. These may include loss of transparency of the lenses of the eyes (juvenile posterior subcapsular opacities), progressive visual impairment, or an increased risk of developing certain tumors of the brain and spinal cord (central nervous system).
NF-2 results from changes (mutations) of a gene on the long arm (q) of chromosome 22 (22q12.2). The NF-2 gene regulates the production of a protein that functions as a tumor suppressor. In some individuals with NF-2, the disorder is caused by new (sporadic) mutations of the gene that occur for unknown reasons. In other affected individuals, NF-2 is inherited as an autosomal dominant trait.
The term "Neurofibromatosis" is sometimes also used to describe a second, distinct form of NF known as Neurofibromatosis Type I (NF-1). More common than NF-2, NF-1 is primarily characterized by the development of multiple noncancerous (benign) tumors of nerves and skin (neurofibromas) and areas of abnormally decreased or increased coloration (hypo- or hyperpigmentation) of the skin, such as pale tan or light brown discolorations (cafe-au-lait spots) on the skin of the trunk or other regions. In contrast, in individuals with NF-2, benign fibrous tumors of the skin (cutaneous neurofibromas) and areas of abnormal pigmentation are considered relatively rare. As with NF-2, NF-1 may be inherited as an autosomal dominant trait or appear to occur randomly due to new (sporadic) genetic changes. .
|
|
"Homeopathy cares for a larger percentage of cases than any other
method of treatment." - Mahatma Gandhi
"The introduction of Homeopathy forced the old school doctor to
stir around and learn something of a rational nature about his business.
You may honestly feel grateful that homeopathy survived the attempts of
the orthodox Physicians to destroy it." - Mark Twain
Click
here for more homeopathy quotes.
Larsons Homeo
Suite 3587
SE-111 74 Stockholm
Sweden
|